tiprankstipranks
Argent Biopharma (RGTLF)
OTHER OTC:RGTLF
Holding RGTLF?
Track your performance easily

Argent Biopharma (RGTLF) Financial Statements

29 Followers

Argent Biopharma Financial Overview

Argent Biopharma's market cap is currently ―. The company's EPS TTM is $-0.351; its P/E ratio is -0.36; Argent Biopharma is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Jun 21Jun 20Jun 19Jun 18
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsAU$ 1.89MAU$ 5.43MAU$ 1.87MAU$ 2.35MAU$ 9.86M
Total AssetsAU$ 18.56MAU$ 24.24MAU$ 7.93MAU$ 13.00MAU$ 19.99M
Total DebtAU$ 4.35MAU$ 6.02MAU$ 1.90MAU$ 0.00AU$ 21.56K
Net DebtAU$ 2.47MAU$ 584.33KAU$ 25.85KAU$ -2.35MAU$ -9.84M
Total LiabilitiesAU$ 13.38MAU$ 10.41MAU$ 4.83MAU$ 2.20MAU$ 7.30M
Stockholders EquityAU$ 5.84MAU$ 13.83MAU$ 3.11MAU$ 10.96MAU$ 13.93M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in AUD

Argent Biopharma Earnings and Revenue History

Argent Biopharma Debt to Assets

Argent Biopharma Cash Flow

Argent Biopharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis